Asset Dedication’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Asset Dedication's UTHR Position: Q3 2026 in Review
Asset Dedication held its United Therapeutics (UTHR) position steady in Q3 2026 at 18 shares worth $9.8K. The position accounts for ﹤0.01% of the portfolio, ranked #797.
Asset Dedication first reported a position in UTHR in Q2 2026 and has held it in 2 quarters since. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Asset Dedication held 18 shares of United Therapeutics worth $9.8K as of Q3 2026.
- Asset Dedication left its United Therapeutics share count unchanged in Q3 2026.
- United Therapeutics made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #797 holding.
- Asset Dedication first reported a position in United Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.